Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial. [electronic resource]
Producer: 19940413Description: 959-68 p. digitalISSN:- 0009-7322
- Canada -- epidemiology
- Cholesterol -- blood
- Coronary Angiography
- Coronary Artery Disease -- diagnostic imaging
- Double-Blind Method
- Female
- Follow-Up Studies
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Lipids -- blood
- Lovastatin -- therapeutic use
- Male
- Middle Aged
- Multivariate Analysis
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.